Earnings Feed
Start Free
Home/Filings/4/0001104659-16-113522
4//SEC Filing

Trovagene, Inc. 4

Accession 0001104659-16-113522

$CRDFCIK 0001213037operating
View on SEC.govCompany Profile

Filed

Apr 21, 8:00 PM ET

Accepted

Apr 22, 4:05 PM ET

Size

10.3 KB

Accession

0001104659-16-113522

Insider Transaction Report

Form 4
Period: 2016-04-21
Trovagene, Inc.TROV
ZANIBONI STEVE
CFO
Transactions
  • Exercise/Conversion

    Stock Options

    2016-04-21−166,667→ 76,250 total
    Exercise: $3.60Exp: 2022-02-01→ Common Stock (71,125 underlying)
  • Exercise/Conversion

    Stock Options

    2016-04-21−15,000→ 61,250 total
    Exercise: $4.39From: 2015-12-11Exp: 2024-12-11→ Common Stock (4,514 underlying)
  • Exercise/Conversion

    Common Stock

    2016-04-21$3.60/sh+71,125$256,050→ 92,454 total
  • Exercise/Conversion

    Common Stock

    2016-04-21$4.39/sh+4,514$19,816→ 96,968 total
Footnotes (1)
  • [F1]41,667 options vested on each of 2/1/2013, 2014, 2015 and 2016.

Documents

1 file

Issuer

Trovagene, Inc.

CIK 0001213037

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001213037

Filing Metadata

Form type
4
Filed
Apr 21, 8:00 PM ET
Accepted
Apr 22, 4:05 PM ET
Size
10.3 KB
View on SEC.gov